SEC Form 4 · accession 0001190251-15-000008

ICU MEDICAL INC/DE · ICUI

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Joseph R Saucedo

Director

Period of report

Oct 5, 2015

Accepted (ET)

Oct 5, 2015 · 7:47 pm EDT

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0000883984

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I
Common Stock	Oct 5, 2015	X	1,875	$24.21	A	3,431	D
Common Stock^F2	Oct 5, 2015	S	978	$106.9888	D	2,453	D
Common Stock^F3	Oct 5, 2015	S	700	$108.3257	D	1,753	D
Common Stock^F4	Oct 5, 2015	S	197	$109.1548	D	1,556	D

Table II — derivative securities

Security	Conv. / exercise price	Date	Code	Shares	A/D	Exercisable	Expires	Underlying	Underlying shares	Owned after	D/I
Non-Qualified Stock Option (right to buy)^F5	$24.21	Oct 5, 2015	X	1,875	D	May 16, 2005	Nov 16, 2015	Common Stock	1,875	0	D

Explanation of responses

F1The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on November 12, 2013.
F2The price recorded in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $106.63 to 107.42, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
F3The price recorded in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $107.79 to 108.72, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
F4The price recorded in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $109.14 to 109.17, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
F5Transaction is the exercise of a derivative security; see Column 2.